| |
Original Artikel |
Datum |
Titel |
Autoren Max. 6 Autoren |
| 1 |
[GO] |
2026―Jul―01 |
A comparative study of circulating biomarkers in patients with COVID-19 and neurodegenerative diseases |
N.N. Sushentseva, S.V. Apalko, A.Yu. Asinovskaya, S.V. Mosenko, A.K. Minochkin, O.S. Popov, A.M. Sarana, S.G. Shcherbak |
| 2 |
[GO] |
2026―Apr―06 |
Analysis of specific humoral immunity to various SARS- CoV-2 strains from COVID-19 patients and anti-COVID-19 vaccinated donors |
T.A. Ivashchenko, Ya.O. Romanenko, A.S. Kartseva, M.A. Marin, A.K. Riabko, A.A. Ershova, I.S. Lutcheva, V.V. Firstova |
| 3 |
[GO] |
2026―Apr―06 |
The state of specific humoral and T cell response to SARS-CоV-2 S- and N-proteins in the post-pandemic period in vaccinated people with a history of COVID-19 |
M.S. Blyakher, I.M. Fedorova, S.I. Koteleva, I.V. Kapustin, S.V. Sandalova, Z.K. Ramazanova, E.E. Odintsov, L.I. Novikova |
| 4 |
[GO] |
2025―Aug―29 |
Pattern of bronchial inflammation in patients with bronchial asthma after COVID-19 |
A.G. Prihodko, A.B. Pirogov, D.A. Gassan, Ju.M. Perelman |
| 5 |
[GO] |
2025―Jul―02 |
Trained immunity and heterologous protection against COVID-19 in risk groups |
M.V. Pashenkov, A.M. Masyutina |
| 6 |
[GO] |
2025―Feb―28 |
Sequencing of Ig genes from single circulating plasmablasts during acute SARS-CoV-2 infection |
M.G. Byazrova, M.M. Sukhova, A.A. Mikhailov, P.P. Guseva, A.F. Romanova, A.G. Prilipov, A.V. Filatov |
| 7 |
[GO] |
2025―Feb―28 |
Significance of cytokines of convalescent plasma for survival of recipients treated for COVID-19. Effects on clinical and laboratory data |
M.P. Potapnev, A.V. Maximovich, I.A. Dunayeu, L.M. Hushchina, F.N. Karpenko, O.V. Krasko |
| 8 |
[GO] |
2024―Mai―23 |
HLA-A, -B, -DRB1 genes polymorphism of in COVID-19 patients |
E.M. Rodnikova, K.R. Dudina, T.E. Yankevich, V.V. Kadochnikova, M.N. Boldyreva, D.Yu. Trofimov |
| 9 |
[GO] |
2024―Mai―23 |
Exploring potential biomarkers for predicting COVID-19 severity and outcome |
N.N. Sushentseva, O.S. Popov, S.V. Apalko, A.Yu. Asinovskaya, S.V. Mosenko, A.M. Sarana, S.G. Shcherbak |
| 10 |
[GO] |
2024―Mrz―12 |
Study of the antigenic specificity of T-cell immune reactions in response to immunization of laboratory mice with a recombinant adenoviral vector encoding the Spike-protein of SARS-CoV-2 |
R.I. Ataullakhanov, E.I. Ushakova, A.V. Pichugin, E.S. Lebedeva, S.V. Ivanov, T.A. Ozharovskaia, O. Popova, D.N. Shcherbinin, A.S. Bandelyuk, O.V. Zubkova, M.M. Shmarov, D.Yu. Logunov, B.S. Naroditsky, A.L. Gintsburg |
| 11 |
[GO] |
2024―Jan―26 |
Dynamics and functional characteristics of antibodies and memory B cells to SARS-CoV-2 in peripheral blood from COVID-19 patients for up to 16 months |
I.S. Vladimirov, A.S. Zhdanova, E.S. Bolashova, V.E. Mukhin, V.V. Makarov, V.S. Yudin, S.A. Kraevoy |
| 12 |
[GO] |
2024―Jan―26 |
Features of cell immunity of healthcare workers in the first wave of the SARS-CoV-2 infection pandemic |
A.A. Borunova, E.K. Shoua, E.N. Zakharova, A.I. Chertkova, Z.G. Kadagidze, I.B. Shoua, T.V. Davydova, N.E. Kushlinskii, I.V. Babkina, N.G. Osipova, A.P. Ternavskii, I.A. Doroshev, P.V. Kononets, I.S. Stilidi, T.N. Zabotina |
| 13 |
[GO] |
2023―Dez―14 |
Study of the antigenic specificity of T-cell immune reactions in response to immunization of laboratory mice with a recombinant adenoviral vector encoding the Spike-protein of SARS-CoV-2 |
R.I. Ataullakhanov, E.I. Ushakova, A.V. Pichugin, E.S. Lebedeva, S.V. Ivanov, T.A. Ozharovskaia, O. Popova, D.N. Shcherbinin, A.S. Bandelyuk, O.V. Zubkova, M.M. Shmarov, D.Yu. Logunov, B.S. Naroditsky, A.L. Gintsburg |
| 14 |
[GO] |
2023―Sep―25 |
Evaluation of the efficacy of different adjuvants in producing murine monoclonal antibodies to the receptor-binding domain of the S-protein of SARS-CoV-2 |
T.A. Ivashchenko, Ya.O. Romanenko, M.A. Marin, A.S. Kartseva, M.V. Silkina, N.A. Zeninskaya, I.G. Shemyakin, V.V. Firstova |
| 15 |
[GO] |
2023―Aug―04 |
MIR 19® - world first specific antiviral drug for COVID-19 treatment: development and preclinical studies |
M.R. Khaitov, A.A. Nikonova, I.P. Shilovskiy, K.V. Kozhikhova, I.A. Kofiadi, G.O. Gudima, L.I. Vishniakova, A.A. Nikolskii, V.I. Kovchina, E.D. Timotievich, K.V. Yumashev, V.V. Smirnov, A.V. Maerle, I.B. Kozlov, A.A. Shatilov, A.V. Shatilova, S.M. Andreev, O.O. Koloskova, N.A. Kuznetsova, D.V. Vasina, M.A. Nikiforova, S.P. Rybalkin, I.V. Sergeev, D.Yu. Trofimov, А.I. Martynov, I.A. Berzin, V.A. Gushchin, A.V. Kovalchuk, S.V. Borisevich, V.I. Skvortsova |
| 16 |
[GO] |
2023―Aug―04 |
Cellular and humoral responses to SARS-CoV-2 (omicron variant) in children and adolescents with pulmonary tuberculosis |
M.M. Averbakh, L.V. Panova, E.S. Ovsyankina, A.E. Ergeshov, T.G. Smirnova, E.A. Kiseleva, Yu.Yu. Khokhlova, S.S. Sterlikova |
| 17 |
[GO] |
2023―Mai―29 |
Dynamics of clinical and immunological parameters in patients underwent a moderate COVID-19 and received therapy with janus kinase inhibitor |
L.P. Sizyakina, N.A. Skripkina, E.A. Antonova, D.P. Sizyakin |
| 18 |
[GO] |
2023―Mai―29 |
Dynamic assessment of the intensity of the immune response to SARS-CoV-2 infection and immunization against COVID-19 with the vaccine «Sputnik V» |
K.O. Nechay, A.I. Andreev, I.V. Andreev, D.R. Esaulova, O.S. Baklakova, M.B. Shadyzheva, L.V. Romanova, V.I. Gegechkori, N.G. Cherchenko, V.I. Vecherko, I.A. Kofiadi, G.O. Gudima, А.I. Martynov, V.V. Smirnov, D.A. Kudlay, M.R. Khaitov |
| 19 |
[GO] |
2023―Mrz―17 |
Changes in the expression of genes encoding ACE2 and innate immunity molecules (TLR7, IFN-α, IL-1β, TNF) in elderly patients with COVID-19 |
V.V. Grechenko, O.S. Uvarova, T.V. Gromova, O.V. Artemyeva, L.V. Gankovskaya |
| 20 |
[GO] |
2023―Mrz―17 |
Humoral immune response to linear and conformational epitopes of SARS-CoV-2 in patients with COVID-19 |
V.A. Shokina, D.S. Matyushkina, D.V. Krivonos, V.A. Manuvera, D.A. Shirokov, D.D. Kharlampieva, V.N. Lazarev, A.V. Pavlenko, E.N. Ilyina, A.G. Rumyantsev, S.A. Roumiantsev, K.P. Ivanov, P.A. Khromova, V.P. Baklaushev, A.V. Koritsky, V.A. Kuropatkin, E.V. Moskaleva, O.B. Ogarkov, E.A. Orlova, A.G. Petrova, N.S. Pozhenko, D.Y. Pushkar, K.B. Kolontarev, N.A. Kolyshkina, L.V. Rychkova, A.S. Samoilov, V.V. Sinkov, S.V. Solovieva, A.V. Troitsky, Yu.D. Udalov, G.M. Yusubalieva, V.M. Govorun |
| 21 |
[GO] |
2023―Mrz―17 |
Impact of SARS-CoV-2-specific cellular and humoral immunity on survival in patients with COVID-19 for the first time |
O.S. Popov, N.N. Sushentseva, I.A. Polkovnikova, S.V. Apalko, A.Yu. Rudnik, A.Yu. Anisenkova, S.V. Kolesnik, D.A. Kudlay, S.V. Mosenko, S.G. Shcherbak |
| 22 |
[GO] |
2023―Mrz―17 |
Severe asthma and COVID-19 in a real clinical practice |
G.R. Sergeeva, A.V. Emelyanov, I.V. Tsukanova, E.V. Leshenkova, A.A. Znakhurenko |
| 23 |
[GO] |
2023―Mrz―17 |
Methodology for evaluation of the level of IgG antibodies against different SARS-CoV-2 proteins using multiplex immunofluorescence analysis |
L.V. Frolova, P.Yu. Zemsky, S.I. Mitrofanov, V.E. Mukhin, T.А. Shpakova, P.G. Kazakova, Yu.N. Akhmerova, N.V. Bulanova, L.A. Golubnikova, K.S. Grammatikati, A.S. Zhdanova, A.A. Mkrtchian, A.P. Sergeev, E.A. Snigir, N.V. Feliz, V.V. Makarov, V.S. Yudin, A.A. Keskinov, S.A. Kraevoy, S.M. Yudin, V.I. Skvortsova |
| 24 |
[GO] |
2022―Nov―14 |
The efficacy of medicinal products based on plasma immunoglobulins and monoclonal antibodies for the treatment and prevention of COVID-19 |
A.A. Soldatov, Zh.I. Avdeeva, D.V. Gorenkov, L.M. Khantimirova, Yu.S. Paramonova, E.M. Smolina, V.P. Bondarev, V.A. Merkulov |
| 25 |
[GO] |
2022―Nov―14 |
Сorrelation between age and the intensity of the post-vaccination humoral immune response in individuals passed COVID-19 |
A.I. Andreev, I.V. Andreev, K.O. Nechay, D.R. Esaulova, O.S. Baklakova, V.I. Vecherko, I.P. Shilovskiy, I.A. Kofiadi, G.O. Gudima, А.I. Martynov, V.V. Smirnov, D.A. Kudlay, M.R. Khaitov |
| 26 |
[GO] |
2022―Nov―14 |
Clinical and immunological characteristics of the postcovid period in patients with moderate-severe COVID-19 who received therapy with the inclusion of an IL-6 receptor antagonist |
L.P. Sizyakina, N.A. Skripkina, E.A. Antonova, D.P. Sizyakin |
| 27 |
[GO] |
2022―Sep―16 |
«Storm» of soluble differentiation molecules in COVID-19 |
V.V. Novikov, A.V. Karaulov |
| 28 |
[GO] |
2022―Sep―16 |
Features of postinfectious immunity formation in a patient with common variable immune deficiency and severe COVID-19 course: a description of a clinical case |
L.P. Sizyakina, I.I. Andreeva, N.A. Skripkina |
| 29 |
[GO] |
2022―Jul―18 |
Interferon system for COVID-19 |
A.N. Narovlyansky, F.I. Ershov, A.V. Sanin, A.V. Pronin |
| 30 |
[GO] |
2022―Jul―18 |
Preventive effectiveness of nasal interferon-gamma among adult volunteers against acute respiratory viral infections, including COVID-19 |
P.A. Talyzin, A.L. Myasnikov, S.A. Berns, M.A. Ilyina, A.A. Komazov, V.S. Lynyov, E.V. Ekusheva |
| 31 |
[GO] |
2022―Jul―18 |
Preventive effectiveness of nasal interferon-gamma among adult volunteers against acute respiratory viral infections, including COVID-19 (in Russian) |
P.A. Talyzin, A.L. Myasnikov, S.A. Berns, M.A. Ilyina, A.A. Komazov, V.S. Lynyov, E.V. Ekusheva |
| 32 |
[GO] |
2022―Mai―16 |
Cytokine patterns of fatal hyperinflammatory conditions, caused by secondary hemophagocytic lymphohistiocytosis, bacterial sepsis and COVID-19 |
M.Yu. Pervakova, V.G. Potapenko, O.Yu. Tkachenko, E.V. Volchkova, O.N. Titova, S.V. Lapin, E.A. Surkova, T.V. Blinova, I.V. Kholopova, D.A. Kuznetsova, A.N. Moshnikova, A.V. Mazing, A.N. Kulikov, Yu.S. Polushin, A.A. Afanasyev, I.V. Shlyk, E.G. Gavrilova, A.V. Klimovich, N.V. Medvedeva, V.L. Emanuel |
| 33 |
[GO] |
2022―Mai―16 |
Anosmia in COVID-19 and allergic rhinitis. Effect of masking on the severity of symptoms |
A.I. Shcherbakov, O.A. Stukolova, A.V. Tutelyan, A.A. Ploskireva, V.G. Akimkin |
| 34 |
[GO] |
2022―Mai―16 |
Dynamics of immune status parameters in patients with COVID-19, receiving therapy with inclusion of an IL-6 receptor antagonist |
L.P. Sizyakina, N.A. Skripkina, E.A. Antonova, V.Ya. Zakurskaya, D.P. Sizyakin |
| 35 |
[GO] |
2022―Mai―16 |
Immunopathogenesis of COVID-19-related pediatric multisystem inflammatory syndrome |
I.M. Osmanov, I.M. Khegai, I.I. Trunina, T.A. Chebotareva, A.A. Cheburkin, P.V. Shumilov |
| 36 |
[GO] |
2022―Apr―11 |
Dynamics of specific humoral response in COVID-19 patients |
V.Ya. Zakurskaya, L.P. Sizyakina, M.V. Kharitonova, S.V. Shlyk |
| 37 |
[GO] |
2022―Apr―11 |
Post-vaccination and post-infection humoral immune response to the SARS-CoV-2 infection |
I.V. Andreev, K.O. Nechay, A.I. Andreev, A.P. Zubaryova, D.R. Esaulova, A.M. Alenova, I.А. Nikolaeva , O.P. Chernyavskaya, K.S. Lomonosov, A.E. Shulzhenko, O.M. Kurbacheva, E.A. Latysheva, N.V. Shartanova, E.V. Nazarova, L.V. Romanova, N.G. Cherchenko, V.V. Smirnov, O.V. Averkov, А.I. Martynov, V.I. Vechorko, G.O. Gudima, D.A. Kudlay, R.M. Khaitov, M.R. Khaitov |
| 38 |
[GO] |
2021―Nov―23 |
Ferritin level as a predictor of COVID-19 severe course |
L.P. Sizyakina, V.Ya. Zakurskaya, N.A. Skripkina, E.A. Antonova |
| 39 |
[GO] |
2021―Sep―13 |
Clinical and immunological correlations in COVID-19: experience of immunomodulatory therapy |
T.V. Khorobryh, G.K. Makhnach, M.V. Volgin, V.V. Khorobryh, N.P. Mishchenko, A.A. Ivashchenko, V.G. Loginov, E.V. Yakubova |
| 40 |
[GO] |
2021―Jul―23 |
Changes in the expression of Toll-like receptors, cytokines and chemokines in the cells of the mucous membrane of the oropharynx in children with COVID-19 |
L.V. Gankovskaya, E.V. Zinina, V.A. Gankovskii, A.R. Semushkin |
| 41 |
[GO] |
2021―Jul―23 |
COVID-19 in children with bronchial asthma: clinical manifestations, course options, approaches to therapy |
N.A. Geppe, N.G. Kolosova, M.D. Shakhnazarova, A.B. Malakhov, Yu.S. Timofeev, V.G. Samartseva, O.S. Glazachev, O.V. Grebneva, E.V. Romantseva, I.I. Kalinovskaya, N.D. Odinaeva |
| 42 |
[GO] |
2021―Jul―23 |
Possible role of anti-IL17 drugs in the management of COVID-19: our own experience and literature review |
E.A. Shatokhina, A.S. Polonskaia, E.A. Mershina, E.M. Seredinina, A.G. Plisyuk, O.A. Georginova, T.N. Krasnova, E.P. Pavlikova, Ya.A. Orlova, V.E. Sinitsyn, L.S. Kruglova, A.A. Kamalov |
| 43 |
[GO] |
2021―Jul―23 |
Molecular immunological aspects of diagnostics, prevention and treatment of coronavirus infection |
G.O. Gudima, R.M. Khaitov, D.A. Kudlay, M.R. Khaitov |
| 44 |
[GO] |
2021―Feb―01 |
Prophylaxis of medium and severe clinical forms of COVID-19 infection with aminodihydrophtalazindione sodium salt (Galavit®) in medical personnel working in the «red zone» |
Sergey V. Kolesov, Dmitry S. Gorbatyuk, Andrey A. Panteleyev, Alexey I. Bernakevich, Konstantin Yu. Ukolov |
| 45 |
[GO] |
2020―Aug―18 |
SARS-CoV-2 virus and other epidemic coronaviruses: pathogenetic and genetic factors for the development of infections |
M.N. Boldyreva |
| 46 |
[GO] |
2020―Aug―18 |
A heterologous virus-vectored vaccine for prevention of Middle East respiratory syndrome induces long protective immune response against MERS-CoV |
A.V. Kovyrshina, I.V. Dolzhikova, D.M. Grousova, M.V. Balyasin, A.G. Botikov, L.V. Panina, I.V. Gordeychuk, S.A. Gulyaev, O.V. Zubkova, T.A. Ozharovskaya, O. Popova, A.I. Tukhvatulin, E.A. Tokarskaya, Ya.V. Simakova, I.B. Esmagambetov, D.V. Shcheblyakov, I.M. Evgrafova, P.G. Deryabin, S.V. Borisevich, B.S. Naroditsky, D.Yu. Logunov, A.L. Gintsburg |
| 47 |
[GO] |
2020―Jun―24 |
Immune response against epidemic coronaviruses |
M.V. Pashenkov, R.M. Khaitov |
| 48 |
[GO] |
2020―Jun―24 |
Immunopathogenic properties of SARS-CoV-2 as a basis for the choice of pathogenetic therapy |
M.P. Kostinov |
|
